Erratum to “Brief Report: Canadian Cancer Trials Group IND.227: A Phase II randomized study of pembrolizumab in patients with advanced malignant pleural mesothelioma (NCT02784171). [Journal of Thoracic Oncology Vol. 18 No. 6: 813–819]”

Authors

Piccirillo MC; Chu Q; Bradbury P; Tu W; Coschi CH; Grosso F; Florescu M; Mencoboni M; Goffin JR; Pagano M

Journal of Thoracic Oncology, Vol. 19, No. 11, pp. 1578–1579

Elsevier

November 2024

10.1016/j.jtho.2024.08.017

1556-0864

John Goffin